Small-molecule inhibitors specifically targeting type III secretion

Infection and Immunity

Volumn 73, Issue 5, 2005, Pages 3104-3114

  Nordfelth, R ^a   Kauppi, A M ^a   Norberg, H A ^b   Wolf Watz, H ^a   Elofsson, M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Innate Pharmaceuticals AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 ALLYLSALICYLALDEHYDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CALCIUM; HYDRAZONE DERIVATIVE; PROTEIN INHIBITOR; SALICYLALDEHYDE; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN E;

ACYLATION; ARTICLE; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG TARGETING; EUKARYOTIC CELL; EXPERIMENTAL MODEL; GENE CONSTRUCT; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REPORTER GENE; YERSINIA PSEUDOTUBERCULOSIS;

ACYLATION; ALDEHYDES; BACTERIAL OUTER MEMBRANE PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HELA CELLS; HUMANS; HYDRAZONES; PROTEIN TRANSPORT; VIRULENCE; YERSINIA PSEUDOTUBERCULOSIS;

EID: 17644371042     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.5.3104-3114.2005     Document Type: Article

References (52)

1. Ainscough, E. W., A. M. Brodie, W. A. Denny, G. J. Finlay, S. A. Gothe, and J. D. Ranford. 1999. Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure-activity relationships. J. Inorg. Biochem. 77:125-133.
2. Alksne, L. E., and S. J. Projan. 2000. Bacterial virulence as a target for antimicrobial chemotherapy. Curr. Opin. Biotechnol. 11:625-636.
3. Allaoui, A., R. Schulte, and G. R. Cornelis. 1995. Mutational analysis of the Yersinia enterocolitica virC operon: characterization of yscE, F, G, I, J, K required for Yop secretion and yscH encoding YopR. Mol. Microbiol. 18:343-355.
4. Anderson, D. M., K. S. Ramamurthi, C. Tam, and O. Schneewind. 2002. YopD and LcrH regulate expression of Yersinia enterocolitica YopQ by a posttranscriptional mechanism and bind to yopQ RNA. J. Bacteriol. 184:1287-1295.
5. Bartra, S., P. Cherepanov, A. Forsberg, and K. Schesser. 2001. The Yersinia YopE and YopH type III effector proteins enhance bacterial proliferation following contact with eukaryotic cells. BMC Microbiol. 1:22.
6. Bell, P. B., Jr., I. Rundquist, I. Svensson, and V. P. Collins. 1987. Use of cytofluorometry to evaluate binding of antibodies to the cytoskeleton of cultured cells. J. Histochem. Cytochem. 35:1381-1388.
7. Carey, K. L., N. J. Westwood, T. J. Mitchison, and G. E. Ward. 2004. A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii. Proc. Natl. Acad. Sci. USA 101:7433-7438.
8. Cornelis, G., C. Sluiters, C. L. de Rouvroit, and T. Michiels. 1989. Homology between virF, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J. Bacteriol. 171:254-262.
9. Cornelis, G., J. C. Vanootegem, and C. Sluiters. 1987. Transcription of the yop regulon from Y. enterocolitica requires trans acting pYV and chromosomal genes. Microb. Pathog. 2:367-379.
10. Cornelis, G. R. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3:742-752.
11. Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735-774.
12. Cornelis, G. R., and H. Wolf-Watz. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23:861-867.
13. Dauzonne, D., and L. Martinez. 1995. Synthesis of the 3-aminoflavone-8-acetic acid. Terahedron Lett. 36:1845-1848.
14. Forsberg, A., and R. Rosqvist. 1993. In vivo expression of virulence genes of Yersinia pseudotuberculosis. Infect. Agents Dis. 2:275-278.
15. Forsberg, A., A. M. Viitanen, M. Skurnik, and H. Wolf-Watz. 1991. The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol. Microbiol. 5:977-986.
16. Forsberg, A., and H. Wolf-Watz. 1988. The virulence protein Yop5 of Yersinia pseudotuberculosis is regulated at transcriptional level by plasmid-plB1-encoded trans-acting elements controlled by temperature and calcium. Mol. Microbiol. 2:121-133.
17. Furste, J. P., W. Pansegrau, R. Frank, H. Blocker, P. Scholz, M. Bagdasarian, and E. Lanka. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131.
18. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-680.
19. Gallegos, M. T., R. Schleif, A. Bairoch, K. Hofmann, and J. L. Ramos. 1997. Arac/XylS family of transcriptional regulators. Microbiol. Mol. Biol. Rev. 61:393-410.
20. Ginocchio, C. C., and J. E. Galan. 1995. Functional conservation among members of the Salmonella typhimurium InvA family of proteins. Infect. Immun. 63:729-732.
21. Hakansson, S., K. Schesser, C. Persson, E. E. Galyov, R. Rosqvist, F. Homble, and H. Wolf-Watz. 1996. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15:5812-5823.
22. Hamilton, E. P., and N. Lee. 1988. Three binding sites for AraC protein are required for autoregulation of araC in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:1749-1753.
23. Holmstrom, A., J. Petterson, R. Rosqvist, S. Hakansson, F. Tafazoli, M. Fallman, K. E. Magnusson, H. Wolf-Watz, and A. Forsberg. 1997. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol. Microbiol. 24:73-91.
24. Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.
25. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague as a biological weapon - medical and public health management. JAMA 283:2281-2290.
26. Kauppi, A. M., R. Nordfelth, U. Hagglund, H. Wolf-Watz, and M. Elofsson. 2003. Salicylanilides are potent inhibitors of type III secretion in Yersinia. Adv. Exp. Med. Biol. 529:97-100.
27. Kauppi, A. M., R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson. 2003. Targeting bacterial virulence. Inhibitors of type III secretion in Yersinia. Chem. Biol. 10:241-249.
28. Knappik, A., and A. Pluckthun. 1994. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. BioTechniques 17:754-761.
29. Lee, Y. M., F. Almqvist, and S. J. Hultgren. 2003. Targeting virulence for antimicrobial chemotherapy. Curr. Opin. Pharmacol. 3:513-519.
30. Linington, R. G., M. Robertson, A. Gauthier, B. B. Finlay, R. van Soest, and R. J. Andersen. 2002. Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org. Lett. 4:4089-4092.
31. Livermore, D. 2004. Can better prescribing turn the tide of resistance? Nat. Rev. Microbiol. 2:73-78.
32. Muller, S., M. F. Feldman, and G. R. Cornelis. 2001. The type III secretion system of Gram-negative bacteria: a potential therapeutic target? Expert Opin. Ther. Targets 5:327-339.
33. Neyt, C., and G. R. Cornelis. 1999. Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol. Microbiol. 33:971-981.
34. Nielsen, S. F., S. B. Christensen, G. Cruciani, A. Kharazmi, and T. Liljefors. 1998. Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis. J. Med. Chem. 41:4819-4832.
35. Nordfelth, R., and H. Wolf-Watz. 2001. YopB of Yersinia enterocolitica is essential for YopE translocation. Infect. Immun. 69:3516-3518.
36. Persson, C., R. Nordfelth, A. Holmstrom, S. Hakansson, R. Rosqvist, and H. Wolf-Watz. 1995. Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol. Microbiol. 18:135-150.
37. Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustafsson, K. E. Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by pathogen target cell contact. Science 273:1231-1233.
38. Poole, K. 2001. Multidrug resistance in Gram-negative bacteria. Curr. Opin. Microbiol. 4:500-508.
39. Rimpilainen, M., A. Forsberg, and H. Wolf-Watz. 1992. A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH. J. Bacteriol. 174:3355-3363.
40. Rosqvist, R., I. Bolin, and H. Wolf-Watz. 1988. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56:2139-2143.
41. Rosqvist, R., A. Forsberg, M. Rimpilainen, T. Bergman, and H. Wolf-Watz. 1990. The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol. Microbiol. 4:657-667.
42. Rosqvist, R., S. Hakansson, A. Forsberg, and H. Wolf-Watz. 1995. Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae. EMBO J. 14:4187-4195.
43. Rosqvist, R., K. E. Magnusson, and H. Wolf-Watz. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972.
44. Rosqvist, R., and H. Wolf-Watz. 1986. Virulence plasmid-associated HeLa cell induced cytotoxicity of Yersinia pseudotuberculosis. Microb. Pathog. 1:229-240.
45. Salyers, A. A., Gupta, A., and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412-416.
46. Skryzpek, E., and S. C. Straley. 1993. LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J. Bacteriol. 175:3520-3528.
47. Tsukahara, K., K. Hata, K. Nakamoto, K. Sagane, N. A. Watanabe, J. Kuromitsu, J. Kai, M. Tsuchiya, F. Ohba, Y. Jigami, K. Yoshimatsu, and T. Nagasu. 2003. Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly. Mol. Microbiol. 48:1029-1042.
48. Walsh, C. 2003. Where will new antibiotics come from? Nat. Rev. Microbiol. 1:65-70.
49. Warabi, K., K. Zimmerman, J. Shen, A. Gauthier, M. Robertson, B. Finlay, R. vanSoest, and R. Andersen. 2004. Pachymoside A - a novel glycolipid isolated from the marine sponge Pachymatisma johnstonia. Can. J. Chem. 82:102-112.
50. Ward, G. E., K. L. Carey, and N. J. Westwood. 2002. Using small molecules to study big questions in cellular microbiology. Cell Microbiol. 4:471-482.
51. Wren, B. W. 2003. The yersiniae - a model genus to study the rapid evolution of bacterial pathogens. Nat. Rev. Microbiol. 1:55-64.
52. Yother, J., T. W. Chamness, and J. D. Goguen. 1986. Temperature- controlled plasmid regulon associated with low calcium response in Yersinia pestis. J. Bacteriol. 165:443-447.